The expanding baby boomer population and the rising geriatric population in the United States and Europe will continue to impact decision-making strategies among global healthcare systems. In addition, changing lifestyles have resulted in chronic diseases, which has boosted the need for healthcare services and post-treatment care. To cater to market demand, nutrition-based solutions and product innovations are on the rise. In this first edition of the Agriculture & Nutrition Opportunity Engine Series, 3 market growth opportunities are explored in-detail; the global Omega-3 Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) ingredients market, the US market for calcium and vitamin D supplements, and the European and US market for lutein & zeaxanthin ingredients. The global Omega-3 EPA and DHA ingredients market will reach $2,181.7 million by 2017, growing at a year-on-year growth rate of 3.9%. The US market for calcium and vitamin D supplements will register a year-on-year growth rate of 4.1% and reach $1,702.9 million by 2017. Finally, The European and US market for lutein & zeaxanthin ingredients will reach $223.1 million by 2017, growing at a year-on-year growth rate of 7.1%
This study focuses on the nutritional ingredient growth opportunities that emerge as a consequence of the ‘greying’ of Europe and North America. The market size for 2016 is provided for each segment and is forecast for 2017.
• The regional scope of the Omega-3 EPA + DHA ingredients market is global, and the end-application segments considered are dietary supplements, infant formula, pharmaceuticals, food & beverage, pet food, and others (clinical nutrition and personal care).
• The regional scope of the calcium and vitamin D supplements market is the United States, with a focus on dietary supplements as an end-application segment.
• The regional scope of the lutein and zeaxanthin ingredients market is the United States and Europe, with a focus on dietary supplements a